N-[(1R,2R)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]-4-Methyl-BenzenesulfonaMide
98%
- Product Code: 70670
CAS:
1034835-90-9
| Molecular Weight: | 547.7296 g./mol | Molecular Formula: | C₃₅H₃₅N₂O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate or active pharmaceutical ingredient (API) in the development of therapeutic agents. Its structural features make it particularly valuable in the design of drugs targeting neurological disorders, such as schizophrenia or bipolar disorder, due to its potential interaction with specific receptors in the brain. Additionally, it may be explored for its efficacy in modulating protein-protein interactions, which is crucial in the treatment of various diseases, including cancer. Researchers also investigate its role in the synthesis of novel compounds with improved pharmacokinetic properties, aiming to enhance drug delivery and efficacy.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿3,780.00 |
+
-
|
| 0.050 | 10-20 days | ฿15,138.00 |
+
-
|
N-[(1R,2R)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]-4-Methyl-BenzenesulfonaMide
This compound is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate or active pharmaceutical ingredient (API) in the development of therapeutic agents. Its structural features make it particularly valuable in the design of drugs targeting neurological disorders, such as schizophrenia or bipolar disorder, due to its potential interaction with specific receptors in the brain. Additionally, it may be explored for its efficacy in modulating protein-protein interactions, which is crucial in the treatment of various diseases, including cancer. Researchers also investigate its role in the synthesis of novel compounds with improved pharmacokinetic properties, aiming to enhance drug delivery and efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :